Naproxen Tablet, Delayed Release
Product Images NDC 90096-161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 90096-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zameer Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Label (Label)
Label for Naproxen Delayed-Release Tablets 500 mg by Zameer Pharmaceuticals LLC. The label includes dosage strength, quantity of 100 tablets, tamper-evident container warning, storage instructions, and barcodes. It specifies oral route and prescription-only status.*
FDA Label Image

Description (Naproxen Description)

Description (Naproxen Description)
Chemical structure of naproxen and naproxen sodium, showing their molecular formulas and molecular weights. The image includes the structural diagram for the naproxen molecule with the carboxyl group indicated and compares naproxen (C14H14O3, mol wt 230.26) to naproxen sodium (C14H13NaO3, mol wt 252.23).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.